Skip to main content

Bayer is investing nearly $100M in diabetes management startup One Drop

The partnership and financing will help accelerate One Drop’s expansion from its current focus on diabetes, high blood pressure and high cholesterol into Bayer’s cardiology, oncology and women’s health portfolio.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.